UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033886
Receipt number R000038644
Scientific Title Effect of Dietary Constituent Ingestion on Substrate Metabolism during Exercise under a Condition of No Change of Body Weight
Date of disclosure of the study information 2018/08/27
Last modified on 2019/05/21 17:37:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Dietary Constituent Ingestion on Substrate Metabolism during Exercise under a Condition of No Change of Body Weight

Acronym

Effect of Dietary Constituent Ingestion on Substrate Metabolism during Exercise

Scientific Title

Effect of Dietary Constituent Ingestion on Substrate Metabolism during Exercise under a Condition of No Change of Body Weight

Scientific Title:Acronym

Effect of Dietary Constituent Ingestion on Substrate Metabolism during Exercise

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of 2-week ingestion of different dietary constituents on substrate metabolism during exercise in subjects who aged from 40 to less than 60 years and does not form an exercise habit

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Substrate oxidation during exercise (maximum rate, AUC)

Key secondary outcomes

Power output and rate of perceived exertion (RPE) at when indicated a maximum rate of substrate oxidation during exercise. Power output, RPE and respiratory exchange ratio at when indicated a ventilation threshold during exercise


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

2-week ingestion of the test food A
Wash out(2 weeks)
2-week ingestion of the placebo
Wash out(2 weeks)
2-week ingestion of the test food B

Interventions/Control_2

2-week ingestion of the test food B
Wash out(2 weeks)
2-week ingestion of the test food A
Wash out(2 weeks)
2-week ingestion of the placebo

Interventions/Control_3

2-week ingestion of the placebo
Wash out(2 weeks)
2-week ingestion of the test food B
Wash out(2 weeks)
2-week ingestion of the test food A

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1)Japanese males and females aged 40 years or older and under 60 years at the time of informed consent acquisition, Japanese males and females who meet the following inclusion criteria for protection of human rights and who do not conflict with the exclusion criteria and are able to comply with the management requirements during the study period.
2)Subjects with BMI of 20.7 to 27.5 in males and 18.8 to 26.0 in females.
3)Non smoker.
4)Persons who have received sufficient explanation on the purpose and content of the research, who have the ability to give consent, who voluntarily volunteers to participate in the research with a good understanding, and who have given written consent to participate in the research.

Key exclusion criteria

1) Currently receiving any medication or ambulatory treatment.
2) Have a history of or complication of serious heart, liver, kidney, cardiovascular system, or blood disorders.
3) Have experienced chest pain or vein abnormalities at rest.
4) Frequent shortness of breath, light-headedness, dizziness, and loss of consciousness.
5) Have a history of drug allergy, food allergy, or allergy to raw materials (milk protein, etc.) used in test foods.
6) Have family member who died suddenly for unknown reasons.
7) Diagnosed with lumbar foot disorders.
8) Taking health foods, supplements, or drugs that may affect fatigue relief.
9) Eat extremely biased meals.
10) Extremely irregular lifestyle habits such as diet and sleep.
11) Suspected of having insomnia (insomnia, sleep apnea syndrome, etc.)
12) Present or past history of psychiatric disorder (depression, etc.)
13) Drug dependence, present illness of alcoholism, previous history.
14) Currently participating in other clinical trials or have participated in other clinical trials within the past 3 months.
15) Irregular working hours, such as those working at night.
16) Feels an effect or pain on the lower back, knee, or body during ascent or descent of stairs, etc.
17) Receiving treatment for rheumatoid arthritis.
18) Have surgery or disease of the knee or routinely use a cane.
19) Body weight fluctuates by +-10 kg or more within 1 year.
20) Wishing to become pregnant during pregnancy, lactation, or during the study period.
21) Difficulties in observing records on various questionnaires.
22) Exercising to maintain or improve physical fitness for at least 60 minutes in total per week.
23) Engaged in physical labor for 10 hours or more in total per week.
24) Scheduled to donate blood or receive vaccination or wishe to donate blood or receive vaccination during the study period.
25) Other, persons who are judged by medical doctor to be inappropriate for the study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Nosaka
Middle name
Last name Naohisa

Organization

The Nisshin OilliO Group, Ltd.

Division name

Central Research Laboratory

Zip code

235-8558

Address

1 Shinmori-cho, Isogo-ku, Yokohama, Kanagawa, 235-8558, Japan

TEL

046-837-2488

Email

n-nosaka@nisshin-oillio.com


Public contact

Name of contact person

1st name Masao
Middle name
Last name Matsuoka

Organization

HUMA R&D CORP

Division name

Clinical Development Division

Zip code

108-0014

Address

Round Cross Tamachi 10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan

TEL

81-3-3431-1260

Homepage URL


Email

matsuoka@huma-rd.co.jp


Sponsor or person

Institute

HUMA R&D CORP

Institute

Department

Personal name



Funding Source

Organization

The Nisshin OilliO Group, Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committees of Nihonbashi Egawa Clinic

Address

2F Kotobuki Build. 1-27-12 Yaesu Chuo-ku, Tokyo 103-0028 Japan

Tel

03-5204-0311

Email

jim@medipharma.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 08 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 10 Day

Date of IRB

2018 Year 08 Month 13 Day

Anticipated trial start date

2018 Year 09 Month 07 Day

Last follow-up date

2018 Year 11 Month 30 Day

Date of closure to data entry

2018 Year 12 Month 02 Day

Date trial data considered complete

2018 Year 12 Month 20 Day

Date analysis concluded

2019 Year 04 Month 10 Day


Other

Other related information



Management information

Registered date

2018 Year 08 Month 24 Day

Last modified on

2019 Year 05 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038644


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name